Defense Advanced Research Projects Agency (DARPA)

Red blood cells
#Collaboration #Defense Advanced Research Projects Agency (DARPA) #Metabolic diseases #Scarlet Therapeutics

Scarlet secures $14m DARPA deal for smart red blood cells

Scarlet Therapeutics has entered into an agreement with the Defense Advanced Research Projects Agency (DARPA) to advance the development of smart red blood cells (SRBCs).   Scarlet will lead a multidisciplinary consortium to develop SRBCs in a programme worth up to $14 million.  The agreement builds on the company’s ability to… Read More

#Business & Investment #News